Literature DB >> 25856243

Supplementary home biofeedback improves quality of life in younger patients with fecal incontinence.

Lynne Bartlett1, Kathryn Sloots, Madeleine Nowak, Yik-Hong Ho.   

Abstract

BACKGROUND: Biofeedback is a scarce, resource-intensive clinical therapy. It is used to treat patients with bowel problems, including fecal incontinence (FI), who fail to respond to simple dietary advice, medication, or pelvic floor exercises. Populations are aging and younger cohorts use technology in managing their health, affording FI self-management opportunities. AIM: Does supplementary home-based biofeedback improve FI and quality of life (QOL)?
METHODS: Seventy-five incontinent participants (12 male), mean age 61.1 years, consented to participate. Thirty-nine patients (5 male) were randomized to the standard biofeedback protocol plus daily home use of a Peritron perineometer (intervention) and 36 patients (7 male) to the standard biofeedback protocol (control). On completion of the study each perineometer exercise session was rated for technique by 2 raters, blinded to the patient and order of sessions.
RESULTS: With the exception of Fecal Incontinence Quality of Life Scale lifestyle improvement (intervention--9.1% vs. controls--0.3%, P=0.026) and embarrassment improvement (intervention--50.0% vs. controls--18.3%, P=0.026), supplementary home biofeedback did not result in greater clinical improvement for the intervention group as a whole. However, on stratification around the mean age, continence and QOL of younger people in the intervention group were significantly better than those of their control counterparts. Graphed perineometer sessions demonstrated high compliance and improvement in exercise technique. Perineometers provided reassurance, motivation, and an exercise reminder ensuring that confidence was achieved quickly.
CONCLUSIONS: Home biofeedback was acceptable and well tolerated by all users. Younger participants significantly benefited from using this technology.

Entities:  

Mesh:

Year:  2015        PMID: 25856243     DOI: 10.1097/MCG.0000000000000143

Source DB:  PubMed          Journal:  J Clin Gastroenterol        ISSN: 0192-0790            Impact factor:   3.062


  2 in total

1.  Tools for fecal incontinence assessment: lessons for inflammatory bowel disease trials based on a systematic review.

Authors:  Ferdinando D'Amico; Steven D Wexner; Carolynne J Vaizey; Célia Gouynou; Silvio Danese; Laurent Peyrin-Biroulet
Journal:  United European Gastroenterol J       Date:  2020-07-17       Impact factor: 4.623

2.  A prospectively collected observational study of pelvic floor muscle strength and erectile function using a novel personalized extracorporeal perineometer.

Authors:  Jung Kwon Kim; Young Ju Lee; Hwanik Kim; Sang Hun Song; Seong Jin Jeong; Seok-Soo Byun
Journal:  Sci Rep       Date:  2021-09-15       Impact factor: 4.379

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.